InProTher: Funding, Investors & Team (Sep 2026)
InProTher is an immunotherapy company dedicated to developing the world’s first adaptive immune therapy capable of targeting immunosuppressive genes of ancient retroviruses.
InProTher has raised $6.5M across 1 funding round on record, the most recent a Seed of $6.5M announced in May 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
InProTher Company Profile and Key Stats
Latest funding round on record: May 2023.
InProTher Funding Rounds
InProTher Founders and Leadership Team
Contact details for the InProTher team: 1 of 1 has an email address on file.
Start 14-day free trial →InProTher Funding Compared to Other Biotechnology Startups
InProTher's latest round of $6.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like InProTher in Biotechnology and Copenhagen
Companies Similar to InProTher
Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several…
Alcolase is a Danish life science start-up that specializes in alcohol flushing.
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on…
ENZIDIA is unleashing the biomanufacturing revolution with an enzyme acceleration revolution
Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat…
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly…
Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The…
Pioneering new sustainable bio-based ingredients
Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or…
EvodiaBio is a company in the bio-industrial sector that develops eco-friendly fragrances for the food and…
Fida Biosystems is a technology that provides the detection and characterization of proteins and…
Chromologics is a company that creates new and original food colorings utilizing natural ingredients. Derived…
InProTher Funding FAQs
What does InProTher do?
InProTher is an immunotherapy company dedicated to developing the world’s first adaptive immune therapy capable of targeting immunosuppressive genes of ancient retroviruses.
How much funding has InProTher raised?
InProTher has raised $6.5M across 1 round on record. The most recent is a Seed of $6.5M announced in May 2023.
When did InProTher last raise funding?
InProTher's most recent funding round on record is a Seed of $6.5M, announced in May 2023.
Who is the CEO of InProTher?
Jordi Naval is listed as CEO at InProTher.
Where is InProTher headquartered?
InProTher is based in Copenhagen, Hovedstaden, Denmark.
How many employees does InProTher have?
InProTher is in the 11-50 employee band.
How does InProTher's funding compare to other Biotechnology startups?
InProTher's latest round of $6.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's InProTher Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for InProTher is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.